Igene Biotechnology, Inc. (IGNE)

Market Cap	1.57K -99.7%
Revenue (ttm)	4.80K -99.9%
Net Income	-2.37M
EPS	-0.00
Shares Out	1.56B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	112,551
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0000 - 0.0000
Beta	-33.59
RSI	40.02
Earnings Date	n/a

About Igene Biotechnology

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, ...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1981
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: IGNE

Financial Performance

In 2009, Igene Biotechnology's revenue was $3.96 million, a decrease of -48.23% compared to the previous year's $7.64 million. Losses were -$140,747, -96.47% less than in 2008.